|

ETHOS ENGAGE: Enhancing Treatment of Hepatitis C in Opioid Substitution Settings

RECRUITINGN/ASponsored by Kirby Institute
Actively Recruiting
PhaseN/A
SponsorKirby Institute
Started2018-05-28
Est. completion2025-01-30
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT03685045

Summary

The overall goals of the ETHOS II Project are to enhance hepatitis C virus (HCV) care in drug treatment clinics and needle and syringe programs (NSPs) in New South Wales and Australia, and to develop a translational framework for subsequent establishment of HCV screening and treatment programs in drug treatment clinics and NSPs across NSW and nationally.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Participant has voluntarily signed the informed consent form;
* 18 years of age or older;
* History of injecting drug use\*;
* Recent injecting drug use (previous six months) or currently receiving OST\*.

  * These criteria will not apply for recruitment from residential rehabilitation centres

Exclusion Criteria:

* Nil

Conditions2

Hepatitis CLiver Disease

Browse More Trials

Liver Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.